CombiMatrix has completed the clinical validation of the BAC array CGH based clinical microarray tests. ATScan is designed to detect known genomic copy-number variations associated with Autism Spectrum Disorder and this test is now available to physicians and consumers.
Filed under: Clinical microarrays, microarray blog, microarray for clinical diagnostics, Next Generation of DNA and RNA Microarrays, personalized medicine, Pharmacogenomics | 3 Comments »











